Results 41 to 50 of about 259,999 (280)

The Irritable Bowel Syndrome [PDF]

open access: yes, 2009
A 45 year old businessman presents at your clinic with a 2 year history of recurrent abdominal pain, associated with frequent bouts of diarrhoea. The pain is relieved by defaecation, but there is often a feeling of incomplete evacuation.
Zammit, Edward
core  

Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed   +5 more
wiley   +1 more source

Fibromyalgia syndrome: the pharmacological treatment options

open access: yesReumatismo, 2011
Fibromyalgia (FM), also known as fibromyalgia syndrome (FMS), is a frequently observed systemic disorder characterized by widespread musculoskeletal pain (1, 2).
A. Marsico   +23 more
doaj   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples   +10 more
wiley   +1 more source

Clinical significance of type of mood disturbance (depressed mood, irritable mood, or anhedonia) in children and adolescents with major depressive disorder

open access: yes, 1994
This study examined the various types of mood disturbances (depressed mood, irritable mood, or anhedonia) exhibited by 60 children and adolescents receiving diagnoses for Major Depressive Disorder (MDD) in the DSM-IV field trials.
Guttman, Diane
core   +3 more sources

Irritability, Depressed Mood, Inattention and Spatial Working Memory in Children and Adolescents with Major Depressive Disorder With/Without Persistent Depressive Disorder

open access: yes, 2020
The specific relationships between sad/low mood, irritability, inattention and spatial working memory (SWM) have not been systematically examined in young people with major depressive disorder with and without persistent depressive disorder.
Vance, A   +3 more
core   +1 more source

The Role of Nitrous Oxide (“Laughing Gas”) in DUID Cases and Its Impact on Driving Fitness

open access: yesDrug Testing and Analysis, EarlyView.
A total number of 39 cases of driving under the influence of nitrous oxide were investigated. Plasma concentrations of 0.22 to 17 mL/L (median:3.7 mL/L) were measured in blood samples withdrawn 38 to 144 min (median: 85 min) after control via Headspace‐GC–MS.
L. Lucuta   +4 more
wiley   +1 more source

Role of Botulinum Toxin in Treatment of Depression: A Review

open access: yesBJPsych Open
Aims: Depressive disorders, as defined by the International Classification of Diseases (11th Revision), involve a depressive mood (feeling sad, irritable, or empty) along with other symptoms affecting a person’s ability to function. Botulinum toxin, used
Qutub Jamali, Mahmoud Ali, Doaa Sadek
doaj   +1 more source

P2.15 IRRITABLE AFFECTIVE TEMPERAMENT IS A PREDICTOR OF PULSE WAVE VELOCITY, WHEREAS HYPERTHYMIC AFFECTIVE TEMPERAMENT DETERMINES AUGMENTATION INDEX IN CHRONIC HYPERTENSION

open access: yesArtery Research, 2015
Background: Affective temperaments (anxious, depressive, cyclothymic, irritable and hyperthymic) are subclinical manifestations of major mood disorders and there is cumulating evidence about their involvement is somatic disorders as well.
János Nemcsik*   +9 more
doaj   +1 more source

Predicting levetiracetam neuropsychiatric adverse effects using graph‐theoretical electroencephalographic network metrics in drug‐naive focal epilepsy: A multicenter longitudinal study

open access: yesEpilepsia, EarlyView.
Abstract Objective Levetiracetam (LEV) is an antiseizure medication approved for focal and generalized epilepsy. Despite its efficacy, neuropsychiatric adverse effects (NP‐AEs) may lead to treatment discontinuation. Quantitative electroencephalographic (qEEG) graph‐theoretical analysis has emerged as a valuable tool for identifying neurophysiological ...
Marco Sferruzzi   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy